Development of CNS metastases and survival in patients with inflammatory breast cancer-Reference-Cited by-同舟云学术

Development of CNS metastases and survival in patients with inflammatory breast cancer

Published:2018-03-26 Issue:11 Volume:124 Page:2299-2305
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Uemura Marc I.¹^ORCID,French John T.¹,Hess Kenneth R.²,Liu Diane²,Raghav Kanwal³,Hortobagyi Gabriel N.⁴,Arun Banu K.⁴,Valero Vicente⁴⁵,Ueno Naoto T.⁴⁵,Alvarez Ricardo H.⁴⁵,Woodward Wendy A.⁴⁵,Debeb Bisrat G.⁴⁵,Moulder Stacy L.⁴,Lim Bora⁴⁵,Tripathy Debu⁴,Ibrahim Nuhad K.⁴

Affiliation:

1. Divison of Cancer Medicine; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston Texas

3. Department of Gastrointestinal Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

4. Department of Breast Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

5. Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

Morgan Welch Inflammatory Breast Cancer Research Program

State of Texas Rare and Aggressive Breast Cancer Research Program

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. Breast carcinoma: pattern of metastasis at autopsy;Lee;J Surg Oncol,1983

2. High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel;Crivellari;Ann Oncol,2001

3. Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab;Olson;Ann Oncol,2013

4. Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease;Cristofanilli;Cancer,2007

5. Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA;Swain;Ann Oncol.,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer Brain Metastasis: A Comprehensive Review;JCO Oncology Practice;2024-05-15

2. Inflammatory breast cancer: Epidemiologic data and therapeutic results;International Review of Cell and Molecular Biology;2024

3. Risk-dependent conditional survival analysis and annual hazard rate of inflammatory breast cancer;European Journal of Surgical Oncology;2023-09

4. Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer;Cancer;2022-10-10

5. Screening brain MRI in inflammatory breast cancer: Is it time?;Cancer;2022-10-10